SEI-1 Inhibitors
SEI-1 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the SEI-1 (also known as EIF3E) protein. SEI-1 is a key component of the eukaryotic translation initiation factor 3 (eIF3) complex, which plays a central role in the initiation phase of protein synthesis. Specifically, SEI-1 is associated with the eIF3 complex's regulatory subunit and is involved in controlling the assembly of the ribosomal pre-initiation complex, promoting translation of specific mRNA molecules. Inhibitors of SEI-1 are designed to interact with this protein, disrupting its function and affecting the translational control of specific genes.
These inhibitors are typically small molecules or compounds that can bind to SEI-1, thereby interfering with its interactions with other components of the eIF3 complex or its target mRNA molecules. By doing so, SEI-1 inhibitors may influence the efficiency of translation initiation, impacting the rate at which specific proteins are synthesized in a cell. Research into SEI-1 inhibitors can offer valuable insights into the intricate mechanisms governing gene expression at the post-transcriptional level and may have implications for various fields of biological and molecular research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib, a CDK4/6 inhibitor, may indirectly affect SEI-1 expression by altering the cell cycle dynamics and the transcriptional regulation of cell cycle-related genes, potentially impacting SEI-1 regulation. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib, a PARP inhibitor, could potentially influence SEI-1 expression by modulating DNA repair pathways and cellular responses to DNA damage, which might impact SEI-1 regulation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol, a cyclin-dependent kinase inhibitor, might affect SEI-1 expression by disrupting the normal progression of the cell cycle and influencing the transcriptional regulation of cell cycle genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, a histone deacetylase inhibitor, may impact SEI-1 expression by altering chromatin structure and gene expression patterns, particularly those involved in cell cycle regulation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, could potentially affect SEI-1 expression by altering protein degradation pathways, thus impacting the cellular environment that regulates gene expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts and could influence SEI-1 expression indirectly by inducing DNA damage and affecting DNA repair pathway signaling. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin might impact SEI-1 expression by intercalating into DNA and affecting DNA replication and transcription processes in cells. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, leading to decreased DNA synthesis. This could indirectly affect SEI-1 expression by altering cellular responses to DNA replication stress. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C, a DNA crosslinking agent, could potentially affect SEI-1 expression by inducing DNA damage and altering the expression of genes involved in DNA repair pathways. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide, an inhibitor of DNA topoisomerase II, might impact SEI-1 expression by disrupting DNA replication and repair processes, potentially affecting the regulation of DNA repair genes. | ||||||